Earnings History Data for Adial Pharmaceuticals, Inc (ADIL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focused on the development of a therapeutic agent for the treatment of alcohol use disorder. The company's lead product consists of AD04 which is in clinical stage. Adial Pharmaceuticals Inc. is based in CHARLOTTESVILLE.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | ADIL | Adial Pharmaceuticals, Inc | 6.66 | -0.38 | -0.50 | -1.14 | Adial Pharmaceuticals reports Q3 results [11/13/2024 3:48 PM] |
1.11 | 0.12 (12.03%) |
1.09 | 0.10 (9.99%) |
0.76 - 4.17 | 1,213,695 | 90,000 | 634,147 | ||
|
||||||||||||||||||
| 13-08-2024 | AH | ADIL | Adial Pharmaceuticals | 4.00 | -0.59 | -0.39 | 0.00 | 0.94 | -0.03 (-3.54%) |
0.94 | -0.03 (-3.55%) |
0.76 - 4.46 | 158,612 | 430,000 | 15,514 | |||
|
|
||||||||||||||||||
| 14-05-2024 | AH | ADIL | Adial Pharmaceuticals | 6.00 | -0.68 | -0.51 | 0.00 | 1.39 | -0.05 (-3.47%) |
1.44 | 0.0 (0.00%) |
0.76 - 14.00 | 136,365 | 160,000 | 7,816 | |||
|
|
||||||||||||||||||
| 21-08-2023 | PM | ADIL | Adial Pharmaceuticals | 4.00 | -1.33 | -1.50 | 0.00 | Adial Pharmaceuticals reports Q2 results [8/21/2023 12:12 PM] |
3.27 | -0.14 (-4.11%) |
3.69 | 0.28 (8.21%) |
3.12 - 15.00 | 124,854 | 190,000 | 40,469 | ||
| 14-11-2022 | PM | 9:15 AM ET (Nov 14) |
ADIL | Adial Pharmaceuticals | 7.00 | -0.12 | -0.18 | 0.00 | Adial Pharmaceuticals GAAP EPS of -$0.12 beats by $0.06 [11/14/2022 9:12 AM] |
0.2771 | 0.0 (-0.68%) |
0.0 | 0.0 (0.00%) |
0.24 - 3.52 | 103,424 | 100,000 | 0 | |
| 16-08-2022 | PM | ADIL | Adial Pharmaceuticals | 14.00 | -0.16 | -0.16 | 0.00 | Adial Pharmaceuticals GAAP EPS of -$0.16 beats by $0.01 [8/16/2022 9:28 AM] |
0.5724 | -0.02 (-3.80%) |
0.0 | 0.0 (0.00%) |
0.45 - 5.08 | 152,389 | 370,000 | 0 | ||